Although limited by sample size and the non-autologous setting inherent to our protocols, these observations may suggest that MV-BiKE efficacy requires a certain degree of tumor cell permissiveness to achieve meaningful BiKE-mediated effects. Here, BMP2K is linked to neoplasm.